MetLife, Inc. $MET Stock Holdings Decreased by Iowa State Bank

Key Points

• Iowa State Bank reduced its holdings in MetLife, Inc. by 8.1%, now owning 47,790 shares worth approximately $3.84 million.
• MetLife recently reported an EPS of $2.02 for the last quarter, missing analysts' expectations, and recorded a year-over-year revenue decline of 2.7%.
• The company declared a quarterly dividend of $0.5675, equating to an annualized dividend of $2.27 and a dividend yield of 2.8%.

Iowa State Bank lowered its position in shares of MetLife, Inc. (NYSE:MET - Free Report) by 8.1% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 47,790 shares of the financial services provider's stock after selling 4,188 shares during the quarter. Iowa State Bank's holdings in MetLife were worth $3,843,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in MET. Brighton Jones LLC boosted its position in shares of MetLife by 9.0% in the fourth quarter. Brighton Jones LLC now owns 4,240 shares of the financial services provider's stock worth $347,000 after buying an additional 351 shares during the period. Vest Financial LLC boosted its position in MetLife by 73.5% during the 1st quarter. Vest Financial LLC now owns 27,161 shares of the financial services provider's stock worth $2,181,000 after acquiring an additional 11,507 shares during the period. UMB Bank n.a. grew its stake in MetLife by 8.9% during the 1st quarter. UMB Bank n.a. now owns 7,586 shares of the financial services provider's stock valued at $609,000 after acquiring an additional 619 shares in the last quarter. KMG Fiduciary Partners LLC increased its holdings in shares of MetLife by 4.4% in the 1st quarter. KMG Fiduciary Partners LLC now owns 56,936 shares of the financial services provider's stock valued at $4,571,000 after purchasing an additional 2,423 shares during the period. Finally, Park Avenue Securities LLC increased its holdings in shares of MetLife by 5.7% in the 1st quarter. Park Avenue Securities LLC now owns 39,409 shares of the financial services provider's stock valued at $3,164,000 after purchasing an additional 2,119 shares during the period. Institutional investors and hedge funds own 94.99% of the company's stock.

MetLife Price Performance

NYSE MET opened at $82.41 on Monday. The firm has a market cap of $54.81 billion, a P/E ratio of 13.97, a price-to-earnings-growth ratio of 0.74 and a beta of 0.86. The stock's 50-day moving average is $79.10 and its two-hundred day moving average is $78.14. MetLife, Inc. has a fifty-two week low of $65.21 and a fifty-two week high of $89.05. The company has a debt-to-equity ratio of 0.57, a current ratio of 0.16 and a quick ratio of 0.16.

MetLife (NYSE:MET - Get Free Report) last issued its quarterly earnings data on Wednesday, August 6th. The financial services provider reported $2.02 EPS for the quarter, missing analysts' consensus estimates of $2.32 by ($0.30). MetLife had a net margin of 5.83% and a return on equity of 19.88%. The company had revenue of $17.34 billion for the quarter, compared to analyst estimates of $18.58 billion. During the same period in the prior year, the company posted $2.28 EPS. The business's revenue was down 2.7% on a year-over-year basis. On average, analysts anticipate that MetLife, Inc. will post 9.65 earnings per share for the current fiscal year.

MetLife Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 9th. Stockholders of record on Tuesday, August 5th were given a $0.5675 dividend. The ex-dividend date of this dividend was Tuesday, August 5th. This represents a $2.27 dividend on an annualized basis and a dividend yield of 2.8%. MetLife's dividend payout ratio (DPR) is currently 38.47%.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on MET. Wolfe Research raised shares of MetLife to a "strong-buy" rating in a research report on Tuesday, September 16th. Weiss Ratings restated a "buy (b)" rating on shares of MetLife in a report on Saturday, September 27th. Jefferies Financial Group increased their price objective on MetLife from $100.00 to $103.00 and gave the stock a "buy" rating in a report on Monday, August 11th. Keefe, Bruyette & Woods lowered their target price on MetLife from $94.00 to $92.00 and set an "outperform" rating on the stock in a research note on Monday, August 11th. Finally, JPMorgan Chase & Co. raised their price target on MetLife from $86.00 to $95.00 and gave the stock an "overweight" rating in a research note on Tuesday, July 8th. One equities research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $94.64.

About MetLife

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.